Autopsy report · NCT06005610
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Cause of deathFunding or business
“Trial terminated by Sponsor.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 1 year 8 months before it stopped.
- 93 participants enrolled.
- Results were posted on the registry 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Sponsor type
- US National Institutes of Health
- Conditions
- HIV I Infection
- Interventions
- Estradiol
- Participants
- 93
- Sites
- 18
- Countries
- Mexico, Peru, Thailand, United States
Trials that died the same way
- A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
“Trial was cancelled by Sponsor” - Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
“Termination of the clinical trial by sponsor.” - Pancreatic Enzyme Supplementation for Celiac Disease
“The trial was terminated prematurely by the sponsor for administrative reasons.” - Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)
“Sponsor decided to cancel this trial.” - Pazopanib in Molecularly Selected Patients With Advanced NSCLC
“Terminated by sponsor”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.